Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HERC4 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | MSRB3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | RAB30 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | CARD8 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
mRNA | CCDC36 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | APOL4 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | CPSF6 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | DENND2C | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | CYP2U1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | VSTM4 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |